-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 J0vVpQAzRbdRs92GBIB6HkxTeLxJoIzyuVNVkNudkxn6Qdgd9zLmekAVKTtB2jZX
 pefxCk0NO//FpK16NYPvpw==

<SEC-DOCUMENT>0000950136-02-001435.txt : 20020513
<SEC-HEADER>0000950136-02-001435.hdr.sgml : 20020513
ACCESSION NUMBER:		0000950136-02-001435
CONFORMED SUBMISSION TYPE:	DFAN14A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20020513

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CLARUS CORP
		CENTRAL INDEX KEY:			0000913277
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-PREPACKAGED SOFTWARE [7372]
		IRS NUMBER:				581972600
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DFAN14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-24277
		FILM NUMBER:		02644143

	BUSINESS ADDRESS:	
		STREET 1:		3970 JOHNS CREEK CT
		STREET 2:		STE 100
		CITY:			SUWANEE
		STATE:			GA
		ZIP:			30024
		BUSINESS PHONE:		7702913900

	MAIL ADDRESS:	
		STREET 1:		3970 JOHNS CREEK CT
		STREET 2:		STE 100
		CITY:			SUWANEE
		STATE:			GA
		ZIP:			30024

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SQL FINANCIALS INTERNATIONAL INC /DE/
		DATE OF NAME CHANGE:	19980911

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			KANDERS WARREN B
		CENTRAL INDEX KEY:			0000935577
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DFAN14A

	BUSINESS ADDRESS:	
		STREET 1:		C/O THE LANGER BIOMEDICS GROUP INC
		STREET 2:		450 COMMACK RD
		CITY:			DEER PARK
		STATE:			NY
		ZIP:			11729
		BUSINESS PHONE:		2035529600

	MAIL ADDRESS:	
		STREET 1:		C/O THE LANGER BIOMEDICS GROUP INC
		STREET 2:		450 COMMACK RD
		CITY:			DEER PARK
		STATE:			NY
		ZIP:			11729
</SEC-HEADER>
<DOCUMENT>
<TYPE>DFAN14A
<SEQUENCE>1
<FILENAME>file001.txt
<DESCRIPTION>DEFINITIVE ADDITIONAL MATERIALS
<TEXT>
<PAGE>

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                  SCHEDULE 14A

                PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE
                         SECURITIES EXCHANGE ACT OF 1934
                                (AMENDMENT NO. )

Filed by the Registrant  [ ]     Filed by a Party other than the Registrant [X]

Check the appropriate box:

[ ]     Preliminary Proxy Statement

[ ]     Confidential, For Use of the Commission Only (as permitted by
        Rule 14a-6(e)(2))

[ ]     Definitive Proxy Statement

[X]     Definitive Additional Materials

[ ]     Soliciting Material Pursuant to Rule 14a-12

                               CLARUS CORPORATION
                (NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)

                                WARREN B. KANDERS
                                BURTT R. EHRLICH
                                NICHOLAS SOKOLOW
    (NAME OF PERSON(S) FILING PROXY STATEMENT, IF OTHER THAN THE REGISTRANT)

Payment of filing fee (Check the appropriate box):

[X]      No fee required.

[ ]      Fee computed on table below per Exchange Act Rules 14a-6(i)(1)
         and 0-11.

     (1) Title of each class of securities to which transaction applies:

     (2) Aggregate number of securities to which transaction applies:

     (3) Per unit price or other underlying value of transaction computed
         pursuant to

<PAGE>

         Exchange Act Rule 0-11 (set forth the amount on which the filing fee is
         calculated and state how it was determined):

     (4) Proposed maximum aggregate value of transaction:

     (5) Total fee paid:

[ ]      Fee paid previously with preliminary materials.

[ ]      Check box if any part of the fee is offset as provided by Exchange Act
Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid
previously. Identify the previous filing by registration statement number, or
the Form or Schedule and the date of its filing.

     (1) Amount previously paid:

     (2) Form, Schedule or Registration Statement No.:

     (3) Filing Party:

     (4) Date Filed:

<PAGE>

                 KANDERS NOMINEES TO CLARUS' BOARD PRESS CLARUS
                  TO ADOPT GOOD CORPORATE GOVERNANCE PRACTICES

Greenwich, Connecticut, May 13, 2002 - Warren B, Kanders, Burtt R. Ehrlich and
Nicholas Sokolow (the "Kanders Nominees"), who collectively own approximately
5.6% of the outstanding common stock of Clarus Corporation (NASDAQ: CLRS)
("Clarus"), urge Clarus to adopt good corporate governance procedures
recommended by Institutional Shareholder Services ("ISS"), a stockholder
advocacy group, to protect stockholders' rights and enhance stockholder value.
Mr. Kanders stated that "as with all of my prior investments, and with a view to
increasing shareholder democracy, the Kanders Nominees will seek to implement
good corporate governance practices endorsed by ISS, including the elimination
of Clarus' staggered Board. This will make all directors accountable to the
stockholders every year." In a letter to ISS, Mr. Kanders highlighted the
differences between the Kanders Nominees' pro-stockholder stance, and those of
the incumbent Clarus Board:

<TABLE>
<CAPTION>
Issues:                                Kanders Nominees                       Management's Nominees
- -------                                ----------------                       ---------------------
<S>                                    <C>                                    <C>
Staggered Board of Directors:          Opposed to a staggered Board, and in   For a staggered Board consisting of
                                       favor of all directors being elected   three classes of directors.
                                       every year.

Board Nominating Committee:            Favors a Nominating Committee          Did not have a Nominating Committee
                                       without any management                 until this proxy season and a member
                                       representation on such committee.      of the committee has a consulting
                                                                              arrangement with Clarus.

Transactions with Clarus:              None.                                  Two directors have consulting and
                                                                              other arrangements with Clarus.

Stock Ownership by Directors:          Favors Directors owning stock as it    All management nominees collectively
                                       aligns directors' interests with       own less than 0.3%.
                                       those of stockholders. Kanders
                                       Nominees have an approximately 5.6%
                                       interest in Clarus.

Management Success:                    Multifold increases in investments.    Have presided over Clarus while:
                                       Armor Holdings - initial investment    over $1.7 Billion in market
                                       at $0.76 per share in January 1996,    capitalization has been lost; over
                                       current value $25.25 per share on      $190 million in losses have been
                                       May 9, 2002; Benson Eyecare -          incurred over two years; 50%
                                       initial investment at $0.375 per       reduction in revenues during 2001
                                       share in January 1992, increased to    compared with 2000; $36.8 million in
                                       $10.25 per share in summer 1995 when   writeoffs of purchased assets; and
                                       investment was sold; Langer, Inc. -    repricing of options for employees.
                                       initial investment at $1.52 per
                                       share in February 2001, current
                                       value $8.25 per share on May 9, 2002.
</TABLE>

<PAGE>

The Kanders Nominees look forward to representing the rights of all stockholders
and maximizing value for all stockholders.

THE KANDERS NOMINEES STRONGLY RECOMMEND THAT YOU VOTE TO PROTECT YOUR INTEREST
AS A CLARUS STOCKHOLDER BY SIGNING, DATING AND RETURNING THE GREEN PROXY CARD.

Messrs. Kanders, Ehrlich and Sokolow have filed a definitive proxy statement
(the "proxy statement") with the Securities and Exchange Commission (the
"Commission"). Please read the proxy statement carefully because it contains
important information, including information regarding Messrs. Kanders, Ehrlich
and Sokolow. You may obtain a free copy of this press release and the proxy
statement at the Commission's website at A free copy of this press release and
the proxy statement may also be obtained from MacKenzie Partners, Inc. at 105
Madison Avenue, New York, NY 10016, toll free telephone number: (800) 322-2885.


</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
